IPPRA / Grant Monitor

2026-09-06
3129Open opportunities
189Tom Love Innovation Hub ≥ 60
0Not yet characterized
580Awaiting detail
2026-09-05Last fetch
Lens
Deadline
Score
Funds
Topic
Category
Tom Love Innovation Hub fit Opportunity Topics Ceiling Posted Closes Days
15 NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Not Allowed) RFA-CA-27-007 · National Institutes of Health · other biomedical clinical public health computing communications 2026-05-21 2026-09-18 12
15 Logistics Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U24 Clinical Trials Not Allowed) RFA-RM-27-015 · National Institutes of Health · other biomedical clinical ai data science computing communications $575,000 2026-06-30 2026-10-02 26
15 Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required) PAR-25-226 · National Institutes of Health · other biomedical clinical public health mental behavioral health 2024-11-22 2026-11-19 74
15 NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Clinical Trial Required) PAR-24-211 · National Institutes of Health · other biomedical clinical public health 2024-07-15 2027-07-12 309
15 Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) PA-24-254 · National Institutes of Health · other biomedical clinical public health education workforce 2024-07-11 2027-07-12 309
15 NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed) PAR-25-358 · National Institutes of Health · other biomedical clinical public health ai data science $150,000 2025-01-10 2028-01-07 488
15 Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional) PAR-25-444 · National Institutes of Health · other biomedical clinical public health agriculture food 2025-11-26 2028-09-25 750
15 Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) PAR-27-012 · National Institutes of Health · other biomedical clinical public health mental behavioral health 2026-03-18 2028-11-02 788
15 Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) PA-26-001 · National Institutes of Health · other biomedical clinical public health ai data science 2025-11-26 2028-11-30 816
15 RFA-DP-18-000 RFA-DP-18-000 · Centers for Disease Control and Prevention - ERA · other public health biomedical clinical 2023-10-20 2030-09-30 1485
15 RFA-CK-18-000 RFA-CK-18-000 · Centers for Disease Control and Prevention - ERA · other public health biomedical clinical 2023-10-20 2030-09-30 1485
15 RFA-CD-18-000 RFA-CD-18-000 · Centers for Disease Control and Prevention - ERA · other public health biomedical clinical 2023-10-20 2030-09-30 1485
15 RFA-SH-18-000 RFA-SH-18-000 · Centers for Disease Control and Prevention - ERA · other public health biomedical clinical 2023-10-19 2030-09-30 1485
10 Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) PA-24-201 · National Institutes of Health · other public health biomedical clinical emergency disaster resilience 2024-04-18 2027-04-18 224
10 Native American Research Centers for Health (NARCH) Planning Grants (R34 - Clinical Trial Not Allowed) PAR-25-441 · National Institutes of Health · other tribal indigenous biomedical clinical public health 2025-08-26 2028-07-07 670
10 RFA-CE-18-000 RFA-CE-18-000 · Centers for Disease Control and Prevention - ERA · other public health biomedical clinical 2023-10-20 2030-09-30 1485
10 RFA-PS-18-000 RFA-PS-18-000 · Centers for Disease Control and Prevention - ERA · other public health biomedical clinical 2023-10-20 2030-09-30 1485
10 RFA-IP-18-000 RFA-IP-18-000 · Centers for Disease Control and Prevention - ERA · other public health biomedical clinical 2023-10-20 2030-09-30 1485
10 RFA-OE-18-000 RFA-OE-18-000 · Centers for Disease Control and Prevention - ERA · other public health biomedical clinical 2023-10-20 2030-09-30 1485
10 RFA-CC-18-000 RFA-CC-18-000 · Centers for Disease Control and Prevention - ERA · other public health biomedical clinical 2023-10-20 2030-09-30 1485
10 RFA-TP-18-000 RFA-TP-18-000 · Centers for Disease Control and Prevention - ERA · other public health biomedical clinical 2023-10-20 2030-09-30 1485
10 RFA-OT-18-000 RFA-OT-18-000 · Centers for Disease Control and Prevention - ERA · other public health biomedical clinical 2023-10-20 2030-09-30 1485
10 RFA-TS-18-000 RFA-TS-18-000 · Centers for Disease Control and Prevention - ERA · other public health biomedical clinical 2023-10-19 2030-09-30 1485
10 RFA-GH-18-000 RFA-GH-18-000 · Centers for Disease Control and Prevention - ERA · other public health biomedical clinical 2023-10-13 2030-09-30 1485
10 RFA-DD-18-000 RFA-DD-18-000 · Centers for Disease Control and Prevention - ERA · other public health 2023-10-13 2030-09-30 1485
5 RFA-EH-18-000 RFA-EH-18-000 · Centers for Disease Control and Prevention - ERA · other public health 2023-10-20 2030-09-30 1485
0 Successor-in-Interest (Type 6 Parent Clinical Trial Optional) PA-24-253 · National Institutes of Health · other biomedical clinical 2024-07-11 2027-07-17 314

27 OF 27 ROWS